Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagan

Showing results (391-400 of 489) with videos related to

Pageof 49
Sort By:
BMC Neurology|November 12, 2016
Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40Yuetiva Deming, Kathleen Black, David Carrell, et al.
Plos Genetics|September 24, 2010
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's diseaseCarlos Cruchaga, John S K Kauwe, Kevin Mayo, et al.
Neurology|December 29, 2017
Associations between [<sup>18</sup>F]AV1451 tau PET and CSF measures of tau pathology in a clinical sampleRenaud La Joie, Alexandre Bejanin, Anne M Fagan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 27, 2020
Relationships between big-five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's diseaseAndrew J Aschenbrenner, Jennifer Petros, Eric McDade, et al.
JAMA Neurology|January 31, 2022
Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer DiseaseYen Ying Lim, Paul Maruff, Nicolas R Barthélemy, et al.
Annals of Clinical and Translational Neurology|October 24, 2018
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectoryPeter A Ljubenkov, Adam M Staffaroni, Julio C Rojas, et al.
Proceedings : a Conference of the American Medical Informatics Association. AMIA Fall Symposium|January 1, 1996
Toward reusable software components at the point of careM S Tuttle, D D Sherertz, N E Olson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2020
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodologyBenjamin L Handen, Ira T Lott, Bradley T Christian, et al.
Scientific Reports|February 13, 2023
Tanshinone IIA-loaded nanoparticles and neural stem cell combination therapy improves gut homeostasis and recovery in a pig ischemic stroke modelJulie H Jeon, Erin E Kaiser, Elizabeth S Waters, et al.
Alzheimer Disease and Associated Disorders|April 30, 2016
Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal IndividualsCatherine M Roe, Peggy P Barco, Denise M Head, et al.
Pageof 49

Showing results (391-400 of 489) with videos related to

Sort By:
Pageof 49
BMC Neurology|November 12, 2016
Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40Yuetiva Deming, Kathleen Black, David Carrell, et al.
Plos Genetics|September 24, 2010
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's diseaseCarlos Cruchaga, John S K Kauwe, Kevin Mayo, et al.
Neurology|December 29, 2017
Associations between [<sup>18</sup>F]AV1451 tau PET and CSF measures of tau pathology in a clinical sampleRenaud La Joie, Alexandre Bejanin, Anne M Fagan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 27, 2020
Relationships between big-five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's diseaseAndrew J Aschenbrenner, Jennifer Petros, Eric McDade, et al.
JAMA Neurology|January 31, 2022
Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer DiseaseYen Ying Lim, Paul Maruff, Nicolas R Barthélemy, et al.
Annals of Clinical and Translational Neurology|October 24, 2018
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectoryPeter A Ljubenkov, Adam M Staffaroni, Julio C Rojas, et al.
Proceedings : a Conference of the American Medical Informatics Association. AMIA Fall Symposium|January 1, 1996
Toward reusable software components at the point of careM S Tuttle, D D Sherertz, N E Olson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2020
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodologyBenjamin L Handen, Ira T Lott, Bradley T Christian, et al.
Scientific Reports|February 13, 2023
Tanshinone IIA-loaded nanoparticles and neural stem cell combination therapy improves gut homeostasis and recovery in a pig ischemic stroke modelJulie H Jeon, Erin E Kaiser, Elizabeth S Waters, et al.
Alzheimer Disease and Associated Disorders|April 30, 2016
Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal IndividualsCatherine M Roe, Peggy P Barco, Denise M Head, et al.
Pageof 49